ClinicalTrials.gg
Not yet recruitingNCT07823023Updated Sep 16, 2026

DeepMedFake-Assisted Detection of Synthetic and Discordant Medical Images

An interventional study of DeepMedFake in Medical Image Integrity Verification, sponsored by Beijing Friendship Hospital. Not yet recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Beijing Friendship Hospital · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This prospective randomized controlled trial will evaluate whether DeepMedFake improves the identification of medical images that require further verification. DeepMedFake is an artificial intelligence-based medical image analysis system that provides an image-authenticity risk assessment, a patient-image consistency risk assessment and a recommendation regarding further verification. Hospital physicians and healthcare audit professionals will participate in a randomized two-period crossover design. Each participant will assess one case set with DeepMedFake assistance and the other without AI assistance. The primary outcome in each cohort is the sensitivity of the final verification decision, evaluated separately in the hospital clinical and healthcare audit cohorts.

02

Conditions studied

  • Medical Image Integrity Verification

Keywords

  • Artificial intelligence
  • Medical imaging
  • Synthetic medical image
  • Patient-information-discordant medical images
03

In context

Lead sponsor

Beijing Friendship Hospital is the lead sponsor of 217 studies on the registry; 94 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older.
  • Able to complete reading periods and all required electronic study procedures.
  • Completed the standardized study training and practice cases.
  • Provided written before participation.

    (1)Hospital clinical cohort participants must also meet the following criteria:

  • Hold a valid physician qualification.
  • Currently practice in ophthalmology, radiology, ultrasound medicine, or a clinical specialty in which imaging of the neurological or cerebrovascular, cardiovascular, thoracic, abdominal, or musculoskeletal domain is routinely reviewed.
  • Have direct professional experience reviewing all imaging modalities and clinical imaging domains assigned to them in the study.
  • Routinely use the assigned medical images for image interpretation, image verification or clinical decision-making.

    (2)Healthcare audit cohort participants must also meet the following criteria:

  • Currently work in healthcare audit, medical reimbursement review, medical-cost review or medical-material verification.
  • Have experience reviewing medical imaging materials as part of their routine work.
  • Have knowledge required to interpret the medical images and patient information presented in the study and to determine whether further verification is required.

Exclusion criteria

Exclusion Criteria:

  • Direct involvement in development of the locked DeepMedFake model, determination of model weights or selection of decision thresholds.
  • Direct involvement in selection or construction of the formal case library or adjudication of the reference standard.
  • Direct involvement in generation or implementation of the reader randomization sequence.
  • Previous participation as a reader in the pilot study.
  • Previous access to any formal study case, case-construction record or reference-standard label.
  • Access to undisclosed study information that could permit advance identification of case type or image-generation method.
  • A financial, professional or other conflict of interest considered likely to compromise independent case assessment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Crossover Sequence A

    Participants undergo unassisted review of case set S1 during Period 1, followed by DeepMedFake-assisted review of case set S2 during Period 2.

    Device: DeepMedFake

  • Experimental
    Crossover Sequence B

    Participants undergo DeepMedFake-assisted review of case set S1 during Period 1, followed by unassisted review of case set S2 during Period 2.

    Device: DeepMedFake

  • Experimental
    Crossover Sequence C

    Participants undergo unassisted review of case set S2 during Period 1, followed by DeepMedFake-assisted review of case set S1 during Period 2.

    Device: DeepMedFake

  • Experimental
    Crossover Sequence D

    Participants undergo DeepMedFake-assisted review of case set S2 during Period 1, followed by unassisted review of case set S1 during Period 2.

    Device: DeepMedFake

Interventions

  • DeviceDeepMedFake

    DeepMedFake is an artificial intelligence-based medical image analysis system designed to support the detection of synthetic medical images and authentic medical images paired with discordant patient information. It provides an image-authenticity risk assessment, a patient-image consistency risk assessment and a recommendation regarding further verification. In this study, DeepMedFake is used as a decision-support tool to assist participants in determining whether the image requires further verification before downstream clinical or healthcare audit use. Final judgments and verification decisions are made by the participants.

06

What researchers measure

Primary outcomes

  1. Reader Performance With and Without DeepMedFake Assistance: Sensitivity of the Final Verification Decision in the Hospital Clinical Cohort

    The percentage of reference-standard abnormal cases assigned to further verification by hospital physicians will be estimated under DeepMedFake-assisted and unassisted review. The effect measure is the absolute percentage-point difference between review conditions.

    Time frame: During both reading periods, up to 4 weeks after randomization

  2. Reader Performance With and Without DeepMedFake Assistance: Sensitivity of the Final Verification Decision in the Healthcare Audit Cohort

    The percentage of reference-standard abnormal cases assigned to further verification by healthcare audit professionals will be estimated under DeepMedFake-assisted and unassisted review. The effect measure is the absolute percentage-point difference between review conditions.

    Time frame: During both reading periods, up to 4 weeks after randomization

Secondary outcomes

  1. Reader Performance With and Without DeepMedFake Assistance: Specificity of the Final Verification Decision in the Hospital Clinical Cohort

    The percentage of authentic, information-matched cases assigned to no further verification by hospital physicians will be estimated under each review condition and compared between conditions.

    Time frame: During both reading periods, up to 4 weeks after randomization

  2. Reader Performance With and Without DeepMedFake Assistance: Specificity of the Final Verification Decision in the Healthcare Audit Cohort

    The percentage of authentic, information-matched cases assigned to no further verification by healthcare audit professionals will be estimated under each review condition and compared between conditions.

    Time frame: During both reading periods, up to 4 weeks after randomization

  3. Sensitivity of the Final Verification Decision for Synthetic Medical Image Cases

    The percentage of reference-standard synthetic-image cases assigned to further verification will be estimated under each review condition. DeepMedFake-assisted and unassisted review will be compared separately within the hospital clinical and healthcare audit cohorts.

    Time frame: During both reading periods, up to 4 weeks after randomization

  4. Sensitivity of the Final Verification Decision in Discordant Cases

    The percentage of authentic images paired with discordant patient information that are assigned to further verification will be estimated under each review condition. DeepMedFake-assisted and unassisted review will be compared separately within the hospital clinical and healthcare audit cohorts.

    Time frame: During both reading periods, up to 4 weeks after randomization

  5. Sensitivity of the Image-Authenticity Judgment

    The percentage of reference-standard synthetic-image cases classified as suspected synthetic images will be estimated under each review condition and compared separately within each reader cohort.

    Time frame: During both reading periods, up to 4 weeks after randomization

  6. Specificity of the Image-Authenticity Judgment

    The percentage of reference-standard authentic-image cases classified as not suspected to be synthetic will be estimated under each review condition and compared separately within each reader cohort.

    Time frame: During both reading periods, up to 4 weeks after randomization

  7. Sensitivity of the Patient-Image Consistency Judgment

    Among authentic images, the percentage of discordant cases classified as discordant with the displayed patient information will be estimated under each review condition and compared separately within each reader cohort. Synthetic-image cases will be excluded from this analysis.

    Time frame: During both reading periods, up to 4 weeks after randomization

  8. Specificity of the Patient-Image Consistency Judgment

    Among authentic images, the percentage of information-matched cases classified as matching the displayed patient information will be estimated under each review condition and compared separately within each reader cohort. Synthetic-image cases will be excluded from this analysis.

    Time frame: During both reading periods, up to 4 weeks after randomization

  9. Case-Level Workflow Time

    Elapsed time in seconds from successful case loading to submission of the final required case-level response, including selection of a proposed first verification pathway when required. Recorded pauses will be excluded. Workflow time will be compared between review conditions separately within each reader cohort.

    Time frame: During both reading periods, up to 4 weeks after randomization

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07823023
Responsible party
Lv, Han (Professor, Beijing Friendship Hospital) — Principal investigator
First posted
Sep 16, 2026
Start date
Sep 20, 2026 (estimated)
Primary completion
Oct 20, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Sep 16, 2026

Study contacts

Han Lv
Contact
chrislvhan@126.com
+8613901073227

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion